NCT04799106Enrolling by invitation
Community Based Strategies for Early Detection of Melanoma
A Pilot Feasibility Study of Community Based Strategies for Early Detection of Melanoma
Source: ClinicalTrials.gov · Last updated 26 Oct 2026
Brief summary (registry, in English)
The purpose of this study is to pilot the use of community education and digital dermatology to increase the early detection of curable melanomas.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 9 Mar 2021
- Start date
- 8 Jul 2024
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Cedars-Sinai Medical Center
- Diseases
- Melanoma
- NCT number
- NCT04799106
What you commit to
- Study type: Observational
- Planned participants: 200
- From 8 Jul 2024 to the primary completion date, 31 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- 18 years and older
- \>1mm lesion thickness with ulceration (T2b) or \>2mm lesion thickness (T3/T4)
- Low socioeconomic status (SES) Non-Latinx White individuals (according to Yost's index SES level based on a principal components analysis)
- Latinx individuals
- Individual resides in semi-rural area, including zip codes within Antelope Valley in Southern California and Salinas in Northern California
- Individual speaks and reads English or Spanish
- Voluntary willingness and comprehension to consent
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Clinica Romero Coordinator of this site? Confirm its status | Los Angeles | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.